GBC Blog
Fred Hutchinson Cancer Research Center Specimen Acquisition Network (SAN) – Specimen and Data Acquisition Network Services Now Available to the University of Washington (UW) Institute of Translation Health Sciences (ITHS) Community
January 27, 2022 – The Specimen Acquisition Network (SAN) was founded in 2019 when Fred Hutch reached out to academic centers across the Pacific Northwest region, spanning from British Columbia to Portland – leveraging connections through the Cascadia Data Alliance – to increase access to and awareness of available resources, share ideas and foster partnerships,…
Read MoreAutism-Related Dietary Preferences Mediate Autism-Gut Microbiome Associations
Published:November 11, 2021DOI:https://doi.org/10.1016/j.cell.2021.10.015 Highlights Summary There is increasing interest in the potential contribution of the gut microbiome to autism spectrum disorder (ASD). However, previous studies have been underpowered and have not been designed to address potential confounding factors in a comprehensive way. We performed a large autism stool metagenomics study (n = 247) based on participants…
Read MoreCould the Gut Microbiome be Linked to Autism?
Researchers are hoping to understand whether the microbes in our guts have a role in the disorder. Before Ethan Loyola reached his first birthday, it was clear that something was wrong with his gut. As a baby, he had been given several courses of antibiotics to treat severe ear infections, after which he experienced foul-smelling,…
Read MoreA Grim Diagnosis – Half The World’s Population Has Limited Access To Diagnostics
Every day, millions of Covid-19 tests are performed around the world. Because of the pandemic, everyone is aware of the importance of diagnostic testing. But, as I pointed out earlier, diagnostic tests are necessary for a wide range of conditions that affect all of us, not just pandemic threats. Good clinical care begins with the first…
Read MoreA Biospecimen Crisis in Biotech?
All crises are not equal, but they all need to be recognised, says Robert Hewitt Robert Hewitt is the founder of Biosample Hub, a new platform that connects biotech companies looking for samples with biobanks that have ethically sourced samples available A dictionary definition of a crisis is a time of great difficulty or danger…
Read MoreMemorandum of Understanding Signed by NCI, FDA and HRSA to Bring Cancer Diagnostic Devices Closer to Patients, Particularly Members of Medically Underserved and Geographically Isolated Communities
On Friday, September 17, 2021, leadership from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Health Resources and Services Administration (HRSA) signed a Memorandum of Understanding (MOU) to support solutions for early cancer detection and diagnosis to improve patient outcomes, quality of life, and reduce health disparities among medically underserved, geographically isolated,…
Read MoreWithdrawal of FDA EUA for CDC 2019-Novel Coronavirus RT-PCR Diagnostic Panel
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have…
Read MoreWCG Guns for a $100M IPO Amid a Boon in the CRO Sector as it Recovers from COVID Chaos
The contract research sector has seen major buyouts and a series of bolt-on deals, and clinical research specialist WCG is the latest to get in on the act as it heads to Wall Street. The nine-year old Princeton, New Jersey-based company, which offers trial help to biopharmas and CROs, made around $500 million last year…
Read MoreParexel Snapped Up, Again, as Goldman Sachs, EQT Spend $8.5B on the CRO
The rumors were true: Whispers grew this year that Parexel, owned for the past four years by Pamplona Capital, was seeking a sale or an IPO. Today, the whispers stopped as the CRO loudly declared it is being bought out for $8.5 billion. The suitors and soon-to-be owners are the Swedish investment firm EQT Private Equity and the…
Read MoreChina Embraces Decentralized Clinical Trial Solutions
Surveys show patients, sponsors and CROs in Chinasee the benefits of virtual and hybrid trials. Concernsremain around regulatory gaps, digital data collectionand study logistics. View White PaperBy MAGGIE MA, Director of Clinical Operations – IQVIA, China
Read More